share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(0.9%),Tang Capital Management, LLC(0.9%), etc.

SEC announcement ·  Feb 14 16:05
Summary by Moomoo AI
On December 31, 2023, Tang Capital Partners, LP, along with Tang Capital Management, LLC, and Kevin Tang, collectively reported a change in their holdings of bluebird bio, Inc. According to the Schedule 13G/A filing with the Securities and Exchange Commission, the group beneficially owns 1,700,000 shares of bluebird bio's common stock, which represents 0.9% of the company's class of securities. The filing indicates that as of the date of the filing, the reporting persons have ceased to be the beneficial owner of more than five percent of the class of securities. The shares are reported to be held with shared voting and dispositive power among the three reporting entities. The filing, dated February 14, 2024, also includes a certification stating that the shares were not acquired for the purpose of changing or influencing the control of the issuer.
On December 31, 2023, Tang Capital Partners, LP, along with Tang Capital Management, LLC, and Kevin Tang, collectively reported a change in their holdings of bluebird bio, Inc. According to the Schedule 13G/A filing with the Securities and Exchange Commission, the group beneficially owns 1,700,000 shares of bluebird bio's common stock, which represents 0.9% of the company's class of securities. The filing indicates that as of the date of the filing, the reporting persons have ceased to be the beneficial owner of more than five percent of the class of securities. The shares are reported to be held with shared voting and dispositive power among the three reporting entities. The filing, dated February 14, 2024, also includes a certification stating that the shares were not acquired for the purpose of changing or influencing the control of the issuer.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more